Lv1
50 积分 2025-07-12 加入
Association between pretreatment emotional distress and immune checkpoint inhibitor response in non-small-cell lung cancer
10天前
已完结
Association between pretreatment emotional distress and neoadjuvant immune checkpoint blockade response in melanoma
10天前
已完结
Efficacy and safety of neoadjuvant ICI combined with chemotherapy in breast cancer from the perspective of a privileged population: a systematic review and meta-analysis
21天前
已完结
KLHL29-mediated DDX3X degradation promotes chemosensitivity by abrogating cell cycle checkpoint in triple-negative breast cancer
21天前
已完结
HIF-1-induced mitochondrial ribosome protein L52: a mechanism for breast cancer cellular adaptation and metastatic initiation in response to hypoxia
21天前
已完结
Modulating tumor physical microenvironment for fueling CAR-T cell therapy
21天前
已完结
Efficacy, safety and exploratory analysis of neoadjuvant tislelizumab (a PD-1 inhibitor) plus nab-paclitaxel followed by epirubicin/cyclophosphamide for triple-negative breast cancer: a phase 2 TREND trial
21天前
已完结
Bispecific PD1-IL2v and anti-PD-L1 break tumor immunity resistance by enhancing stem-like tumor-reactive CD8+ T cells and reprogramming macrophages
23天前
已完结
Neuro-immune cross-talk in cancer
27天前
已完结
The association between the neuroendocrine system and the tumor immune microenvironment: Emerging directions for cancer immunotherapy
27天前
已完结
皖公网安备34019202002308
